- Report
- November 2024
- 150 Pages
Global
From €5289EUR$5,950USD£4,591GBP
- Report
- December 2024
- 200 Pages
Global
From €2222EUR$2,500USD£1,929GBP
- Report
- October 2025
- 192 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- October 2025
- 396 Pages
Global
From €5200EUR$5,850USD£4,514GBP
- Report
- July 2025
- 175 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- November 2024
- 150 Pages
Global
From €5289EUR$5,950USD£4,591GBP
- Report
- April 2025
- 143 Pages
Global
From €2666EUR$2,999USD£2,314GBP
- Report
- January 2025
- 135 Pages
Global
From €2666EUR$2,999USD£2,314GBP
- Report
- August 2025
- 195 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- August 2025
- 199 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- August 2025
- 180 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- April 2025
- 200 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- March 2025
- 200 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- August 2025
- 192 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- October 2025
- 181 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- October 2025
- 184 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- October 2025
- 184 Pages
Global
From €3151EUR$3,545USD£2,735GBP
€3501EUR$3,939USD£3,039GBP
- Report
- September 2025
- 250 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- March 2025
- 200 Pages
Global
From €3991EUR$4,490USD£3,464GBP
- Report
- January 2025
- 175 Pages
Global
From €3991EUR$4,490USD£3,464GBP

The Demineralized Bone Matrix (DBM) market is a subset of the larger biomaterials industry. DBM is a type of bone graft material that is used to repair and regenerate bone tissue. It is composed of collagen and other proteins, and is processed to remove the mineral content. DBM is used in a variety of orthopedic and dental procedures, including spinal fusion, fracture repair, and dental implantation. It is also used in reconstructive surgery, such as facial reconstruction.
DBM is a growing market, with increasing demand for its use in a variety of medical procedures. It is a cost-effective alternative to autografts, and is gaining popularity due to its biocompatibility and ability to promote bone regeneration.
Some companies in the DBM market include Zimmer Biomet, Medtronic, Stryker, and Orthofix. Show Less Read more